Capital Wealth Planning’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,120
Closed -$222K 273
2019
Q3
$222K Sell
2,120
-100
-5% -$9.5K 0.01% 228
2019
Q2
$205K Buy
+2,220
New +$211K 0.01% 231
2017
Q4
Sell
-2,000
Closed -$292K 163
2017
Q3
$292K Buy
+2,000
New +$272K 0.23% 53
2017
Q2
Sell
-2,000
Closed -$249K 122
2017
Q1
$249K Hold
2,000
0.21% 54
2016
Q4
$231K Buy
+2,000
New +$223K 0.2% 61

Other funds holding CELG

Capital Wealth Planning's CELG Position: Q4 2019 in Review

Capital Wealth Planning sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,120 shares — an estimated $222K sold.

Capital Wealth Planning first reported a position in CELG in Q4 2016 and held it in 5 quarters. The position peaked at $292K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Capital Wealth Planning reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Capital Wealth Planning sold 2,120 Celgene Corp shares in Q4 2019, an estimated $222K.
  • Capital Wealth Planning first reported a position in Celgene Corp in Q4 2016 and held it in 5 quarters.
  • Capital Wealth Planning's Celgene Corp position peaked at $292K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Capital Wealth Planning's 13F filing for Q4 2019, filed 26 Feb 2020.